By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


JCR Pharmaceuticals 


ASHIYA CITY HYOGO 659-0021      Japan
Phone: 81-797-328591 Fax:



Company News
JCR Pharmaceuticals And Teijin Limited To Develop Allogeneic Regenerative Medical Product Using Dental Pulp Stem Cells (DPCs) 7/18/2017 9:49:49 AM
Mesoblast (MSB.AX) Partner JCR Pharmaceuticals Receives Recommendation For Approval Of Mesenchymal Stem Cell Product In Japan 9/4/2015 7:06:59 AM
Japanese Biotech JCR Pharmaceuticals Selects Medidata’s Cloud-Based Platform To Power Rare Disease Clinical Research In Japan 6/25/2015 3:42:41 PM
Mesoblast Limited (MSB.AX) Partner JCR Pharmaceuticals Files For Marketing Approval Of The First Allogeneic Stem Cell Product In Japan 10/1/2014 7:51:20 AM
Plasticell Signs Deal With JCR Pharmaceuticals To Use Combicult ® Stem Cell Technology In Japan 2/24/2014 9:31:45 AM
TPG Biotech to Fund Development of JCR Pharmaceuticals Drug Candidates 3/12/2008 9:30:33 AM
Osiris Therapeutics, Inc. (OSIR) to Receive Milestone Payment from JCR Pharmaceuticals 1/7/2008 8:28:21 AM
Kissei Pharmaceutical Co., Ltd. And JCR Pharmaceuticals Enter Into Joint Research Agreement For JR-013, Recombinant Human Erythropoietin-Based Renal Anemia Agent 12/27/2005 11:32:27 AM
Fuji Pharmaceutical Co., Ltd. And, JCR Pharmaceuticals Dissolve Partnership In Renal Anemia Drug Development 11/14/2005 12:19:07 PM
CepTor Corporation (CEPO.OB) To Receive $1.5 Million From JCR Pharmaceuticals Upon IND Filing 10/20/2005 3:05:46 PM